Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41582-020-00445-w http://scihub22266oqcxt.onion/10.1038/s41582-020-00445-w 33340023!7747002!33340023     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33340023&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Nat+Rev+Neurol 2021 ; 17 (2): 71-72 Nephropedia Template TP {{tp|p=33340023|t=2021. COVID-19 and the neurological disease therapeutic pipeline |pdf=|usr=}}{{33340023}} gab.com Text COVID-19 and the neurological disease therapeutic pipeline JO: Nat Rev Neurol http://www.kidney.de/pget.php?&tw=1&pmid=33340023 #FOAvip From the interruption of clinical trials by shelter-in-place orders to the challenges involved in safely collecting biofluid samples, drug development for neurological disease was hit hard by the COVID-19 pandemic this year. However, the field has responded with innovative solutions, and 2021 could see the therapeutic pipeline flowing again. Twit Text FOAVip COVID-19 and the neurological disease therapeutic pipeline ????Nat Rev Neurol http://www.kidney.de/pget.php?&tw=1&pmid=33340023 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33340023 #FOAvip English Wikipedia <ref>{{Cite pmid|33340023}}</ref> COVID-19 and the neurological disease therapeutic pipeline #MMPMID33340023 Jicha GA; Abner EL Nat Rev Neurol 2021[Feb]; 17 (2): 71-72 PMID33340023show ga From the interruption of clinical trials by shelter-in-place orders to the challenges involved in safely collecting biofluid samples, drug development for neurological disease was hit hard by the COVID-19 pandemic this year. However, the field has responded with innovative solutions, and 2021 could see the therapeutic pipeline flowing again. |COVID-19/epidemiology/*prevention & control/transmission[MESH] |Clinical Trials as Topic/*organization & administration[MESH] |Communicable Disease Control/*organization & administration[MESH] |Drug Development/*organization & administration[MESH] |Humans[MESH]COVID-19 and the neurological disease therapeutic pipeline (epmc).pdf DeepDyve Pubget Overpricing